563751.fig.003a
(a)
563751.fig.003b
(b)
563751.fig.003c
(c)
563751.fig.003d
(d)
563751.fig.003e
(e)
563751.fig.003f
(f)
Figure 3: The distribution of aGVHD and non-GVHD patients in stage 1, stage 2, and stage 3 (red, aGVHD; green, non-GVHD). (a) classification effect of the first two peaks (5910 Da; 2957.7 Da) from list of values in stage 1; (b) comparison of the expression of peak 7781.9 Da between aGVHD and non-GVHD patients in stage 1, ; (c) classification effect of the first two peaks (3245.6 Da; 2026 Da) in stage 2; (d) comparison of the expression of peak 3245.6 Da in stage 2, ; (e) classification effect of the first two peaks (2935.4 Da; 3195.6 Da) in stage 3; (f) comparison of the expression of peak 2935.4 Da in stage 3, .